HE4 biomarker predicts risk in AHF with CKD

dovepress.com

Acute heart failure (AHF) combined with chronic kidney disease (CKD) poses a significant risk, with readmission rates up to 44% and a mortality rate of 30% within a year. Human epididymis protein 4 (HE4) emerges as a promising biomarker for prognosis, showing a positive correlation with NT-proBNP and a negative correlation with eGFR. Patients with HE4 levels >276.15 pmol/L have a 2.52-fold higher risk of adverse events.


With a significance score of 4, this news ranks in the top 3.7% of today's 24104 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


HE4 biomarker predicts risk in AHF with CKD | News Minimalist